bladder cancer
Novigenix Wins €1.8M EU Grant to Work With Cancer Biomarker Consortium
The Swiss cancer liquid biopsy firm will contribute its expertise and technologies including its AI-driven LITOSeek liquid biopsy platform.
Genomictree Closing in on South Korea Approval for Bladder Cancer MDx, Aims to Begin US Trials Soon
Premium
Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.
NIH Awards Early is Good $1.6M for Bladder Cancer Monitoring Test
The firm said that it will use the money to support the clinical validation of its urine-based BCDx multiomic test to detect bladder cancer recurrence.
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
Apr 5, 2024
Nov 27, 2023
Mar 24, 2023
Feb 15, 2023
Jun 17, 2022